Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Brk Y165-p , Y664-p
CKB Y327-p
FAK Y165-p , Y410-p
Src Y128-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Brk Y165-p , Y664-p
CKB Y327-p
Etk Y12-p
Phosphatases, in vitro:
PTPN14 Y128-p
Putative upstream phosphatases:
PTPN14 Y128-p
Regulatory protein:
BCAR3 S139-p , Y165-p , S437-p , S639-p
DOCK1 Y249-p
EGFR Y267-p , Y327-p , Y410-p
Etk Y12-p
LOX Y249-p
NDRG1 Y249-p , Y410-p
NRP1 Y249-p
PLEKHA7 Y165-p
PTPRJ Y410-p
PXN iso2 Y165-p
Src Y12-p , Y249-p , Y410-p
uPAR Y410-p
Treatment:
collagen_IV Y165-p
dasatinib Y165-p , Y410-p
EGF Y410-p
ephrin_B1 Y234-p , Y387-p
ephrin_B2 Y234-p
erlotinib Y234-p , Y249-p
FGF2 Y234-p
fibronectin Y249-p
HGF Y128-p , Y234-p , Y249-p , Y267-p , Y287-p , Y306-p , Y327-p , Y387-p
ischemia Y249-p , Y387-p , S694-p
metastatic potential Y362-p , Y664-p
nocodazole S134-p , S139-p
pazopanib Y410-p
PDGF Y165-p
PF-573228 Y165-p
saracatinib Y249-p
serum Y165-p , Y249-p